Fundraising FoxMagstim Group
San Francisco, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Magstim Group
Sign up to see every warm intro you have to Magstim Group
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Magstim Group team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
Founders & leadership
Board
TA
Thomas A. RaffinBoard director
JM
Investors · 1
Reported raises · per SEC filings
Form D private placements$32.1M disclosed across 1 round · 2015
▶$32.1MraisedOct 2015 · 2 investors · OtherRule 506(b)
▶$32.1MraisedOct 2015 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Thomas A. RaffinExecutive Officer, Director
- J. Matthew MackowskiExecutive Officer, Director
- Offering amount
- $32.1M
- Amount sold
- $32.1M
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
neurocare groupneurocare group operates a network of over 20 clinics across Europe, the United States, and Australia offering personalized mental health treatments such as TMS, neurofeedback, and tDCS for conditions including depression, ADHD, OCD, and sleep disorders. It also provides a Digital Therapy Platform and an online academy that trains third-party clinicians in its treatment protocols.
BrainswayBrainsWay develops Deep TMS (Transcranial Magnetic Stimulation) systems for treating psychiatric and neurological conditions including depression, OCD, and smoking addiction. The platform includes brain-targeting stimulators with patented H-Coils, patient management capabilities, and clinical research-grade variants for healthcare providers.
NeuroneticsNeuronetics manufactures and sells the NeuroStar Advanced Therapy System, a transcranial magnetic stimulation device used in office-based treatment of major depressive disorder and other mental health conditions, along with operating a network of treatment centers that provide both NeuroStar therapy and esketamine treatment to patients.
Companies working in the same space as Magstim Group.
Frequently asked questions
- What does Magstim Group do?
- Magstim develops neurotechnology and neurostimulation devices for healthcare providers and researchers, focusing on neuromodulation and neurophysiology applications. The company manufactures and supports innovative medical devices used in patient care and neuroscience research globally.
- Who are Magstim Group's investors?
- Magstim Group's investors include Telegraph Hill Partners.
- How much funding has Magstim Group raised?
- Magstim Group has disclosed $32.1M raised across 1 round.
- Where is Magstim Group headquartered?
- Magstim Group is headquartered in San Francisco, US.